Augmented Dicky-Fuller tests for unit roots. by Taimoor Ahmad (8940146)

“…A one percent increase in vaccinations decreased deaths by 0.38% (95% CI: -0.67, -0.08) in wave 5 and the association is statistically significant.…”

Trajectory scores decrease during learning. by Chenguang Zhang (457185)

“…Black lines indicate linear fits. We observed significant decreasing trends (*<i>p <</i> 0.05, * * <i>p <</i> 0.001), except for the left target for Monkey T and the downwards target for Monkey K.…”

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

PRS predicting cognitive decline at the most predictive threshold in each cohort separately and following meta-analysis. by Jack Euesden (3390296)

We compared the Fugl-Meyer (FMA) clinical assessment scores for individuals with stroke with their performance for each outcome measure. by Devin Sean Austin (20285144)

DataSheet1_Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients.docx by Halil Ibrahim Toy (10533263)

“…Formoterol significantly prevented decreases in CBF induced by capsaicin. …”

Datasets used in the study. by Rajon Banik (12066099)

“…</p><p>Conclusion</p><p>The findings indicate a significant increase in the availability of health facilities offering modern family planning services in Bangladesh; however, a slight decline has been observed in their overall mean readiness score. …”

Supplemental data_Role of transient receptor potential vanilloid 4 in therapeutic anti-fibrotic effects of pirfenidone by Koji Kuronuma (9638138)

“…Finally, we showed that changes in forced vital capacity of patients with IPF treated with pirfenidone were significantly correlated with metabolite levels of TRPV4 endogenous ligands in bronchoalveolar lavage fluid. …”

Supporting information_Role of transient receptor potential vanilloid 4 in therapeutic anti-fibrotic effects of pirfenidone by Koji Kuronuma (9638138)

“…Finally, we showed that changes in forced vital capacity of patients with IPF treated with pirfenidone were significantly correlated with metabolite levels of TRPV4 endogenous ligands in bronchoalveolar lavage fluid. …”

Role of transient receptor potential vanilloid 4 in therapeutic anti-fibrotic effects of pirfenidone by Koji Kuronuma (9638138)

“…Finally, we showed that changes in forced vital capacity of patients with IPF treated with pirfenidone were significantly correlated with metabolite levels of TRPV4 endogenous ligands in bronchoalveolar lavage fluid. …”

Details of intervention by groups. by Payal Seth (20797011)

“…The control group did not receive any intervention.</p><p>Results</p><p>We find that the removal of information and credit constraints at a <i>near</i>-<i>universal</i> level in cluster A resulted in improved toilet access and adoption, eliminating OD at the community level, with a significant gain in child weight-for-age z-scores (WAZ scores). …”

Treatment impacts on hygiene behavior. by Payal Seth (20797011)

“…The control group did not receive any intervention.</p><p>Results</p><p>We find that the removal of information and credit constraints at a <i>near</i>-<i>universal</i> level in cluster A resulted in improved toilet access and adoption, eliminating OD at the community level, with a significant gain in child weight-for-age z-scores (WAZ scores). …”

Baseline epidemiological and clinical characteristics according to dose in patients treated with pirfenidone (n = 100). by Eung Gu Lee (7492319)

Subjects:

Comparison of incidence of adverse events between patients who were treated with full recommended dose of pirfenidone (1800mg/d) and relatively low dose of pirfenidone (600mg/d or... by Eung Gu Lee (7492319)

Subjects:

Overall survival of IPF patients according to the pirfenidone dose–full recommended dose of 1800 mg/day vs. relatively low-dose of 1200 mg/day or less. by Eung Gu Lee (7492319)

Subjects:

Comparison of cause of pirfenidone discontinuation between patients who were treated with full recommended dose of pirfenidone (1800mg/d) and relatively low dose of pirfenidone (60... by Eung Gu Lee (7492319)

Subjects:

S1 Data - by Eung Gu Lee (7492319)

Subjects:

Overall survival of IPF patients on pirfenidone and no-antifibrotic treatment. by Eung Gu Lee (7492319)

Subjects:

Baseline epidemiological and clinical characteristics of the enrolled patients. by Eung Gu Lee (7492319)

Subjects:

Effects of pirfenidone treatment on mortality using Cox proportional hazard regression model. by Eung Gu Lee (7492319)

Subjects: